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A B S T R A C T
One of the world highest prevalence estimates of myotonic dystrophy (DM) has been
reported in the Croatian region Istria. To analyse the population genetic characteristics
of DM locus in Istria, two intragenic and three extragenic polymorphic markers were
tested. The Southern blot technique was used for D19S63 locus analysis, whereas PCR
analysis was performed for CKMM, Alu polymorphism, DMPK (G/T) intron 9/HinfI
polymorphism, and D19S207 genetic markers. The compound haplotypes segregating
with DM were established. A complete association between the DM mutation and D19S63,
D19S207, intron 9/HinfI polymorphism and Alu polymorphism markers were found.
In all DM chromosomes: D19S63 and Alu markers had the allele 1 in common; D19S207
had the allele 3 in common, DMPK (G/T) intron 9/HinfI marker had the allele 2 in
common. The analysis of CKMM polymorphism revealed genotype heterogeneity; in DM
chromosomes either allele 2 or allele 4 were found.
The haplotype analysis in the population of Croatian Istria supports the linkage dis-
equilibrium between the DM mutation and Alu polymorphism, intron 9/HinfI polymor-
phism, D19S63 and D19S207 markers as reported worldwide. The results of the hap-
lotype analysis suggest a common origin of the mutation in Istrian population.
Introduction
Myotonic dystrophy (DM) is the most
common muscular dystrophy in adults and
one of the most frequent autosomal domi-
nant diseases1. Great differences in pre-
valence estimates worldwide could be ex-
plained by ascertainment bias and by the
absence of specific diagnostic tests provided
by recent molecular genetic techniques.
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The approach to the localization of the
DM gene was based on the principles of
the reverse genetics. Over the last years,
several informative DNA markers have
been identified for the mapping and clon-
ing of the DM gene 2–4. The genetic defect
underlying DM is now known to be the
expansion of the CTG repeats at the 3’
end of myotonin protein kinase gene5–11.
These molecular tools have recently shed
light on the origins, maintenance and po-
pulation genetic characteristics of DM.
A significant linkage disequilibrium
between DM mutation and some nearby
DNA polymorphic loci has been detected
in different investigated inbred and out-
bred populations: English, French, Span-
ish, Finnish, French-Canadian4,12–14. The-
se findings suggest that most of mutated
alleles are the consequence of a unique or
a small number of ancestral mutations.
On the other hand, the increased number
of (CTG) motifs as the cause of DM was
found in almost all chromosomes from all
investigated populations5–11,15. Therefore,
molecular investigations support the idea
of a unique DM mutation.
In Istria, a northwest Croatian region,
a high DM prevalence of 18/100 000 was
estimated after the inclusion of mutation
analysis as a diagnostic test16. Usually, a
high DM prevalence in genetic isolates
has been explained by the founder effect17.
To investigate the population genetic
characteristics of DM in Istria, the intra-
genic genetic markers Alu18 and DMPK
(G/T) intron 9/HinfI polymorphism19 and
the extragenic markers D19S634 and
D19S20720, all in linkage disequilibrium
with the DM mutation, and the extra-
genic CKMM21 marker, the most distant
to DM mutation proximally, were used.
Patients and Methods
Patients
DM patients were ascertained as re-
ported previously22. All living Istrian pa-
tients identified as DM were included in
the study.
The study sample consisted of 40 sub-
jects from 9 families: 27 DM patients and
13 first-degree relatives; additionally, 10
healthy spouses were analyzed.
Methods
The genetic polymorphism analysis was
aimed at defining the haplotypes around
the DM gene characteristic of the disease
and involved the analysis of five genetic
markers close-linked to DM mutation:
CKMM and D19S63 loci proximal to the
DM gene, the intragenic Alu polymorphic
locus distal to the DM mutation, the in-
tragenic intron 9 (G/T) HinfI polymor-
phism, and D19S207 telomeric to the DM
gene.
The PCR analysis was performed to
amplify the CKMM region. After the dou-
ble digestion with NcoI and TaqI, four dif-
ferent haplotypes resulted: haplotype 1 =
TaqI and NcoI site absent; haplotype 4
= both sites present; haplotype 3 = only
TaqI site present; haplotype 2 = only the
NcoI site present21.
The marker D19S63, in linkage dis-
equilibrium with the DM mutation4, was
analyzed using Southern blot method. The
probe pD10 (D19S63) has been described
in details4. Seven  g of DNA were di-
gested with PvuII, transferred to a nylon
membrane and hybridized with DIG-la-
belled pD10 probe. The detection was done
using non radioactive DIG luminescent
detection kit (Boehringer Mannheim,
Germany)16. The probe pD10 shows 3
allelic PvuII polymorphic fragments of
sizes 1: 6.0 kb, 2: 5.6 kb and 3: 5.4 kb, re-
spectively.
The intragenic Alu marker is in com-
plete linkage disequilibrium with the DM
mutation. The PCR technique was per-
formed using the conditions described
elsewhere18. This polymorphism is due to
insertion/deletion event of Alu repeats,
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and consequently, the amplification pro-
vides the following results: allele 1, 1008
bp, and allele 2, 494 bp.
The DMPK intron 9/HinfI polymor-
phism is a RFLPs polymorphism due to
single nucleotide substitution (G/T)19. The
altered enzyme restriction site is detected
after PCR amplification23. The two alleles
detected are: allele 1: 434 bp, allele 2: 354
bp.
The microsatellite marker GJ-VSSM2
(D19S207) located 15 kb telomeric to the
DM gene was analysed as described by
Jansen et al.20. Significant linkage dis-
equilibrium between the DM mutation
and certain alleles of this marker was
observed23,24. After PCR amplification fi-
ve (CA)n repeat alleles were observed at
the microsatellite: allele 1: 157 bp, allele
2: 153 bp, allele 3: 151 bp, allele 4: 149 bp,
allele 5: 145 bp20.
Compound haplotypes segregating with
DM were also established.
Results
Twenty-seven DM patients, 13 close
relatives and 10 healthy spouses were an-
alyzed with five nearby polymorphic ge-
netic markers: CKMM polymorphism,
D19S63 polymorphism, Alu polymorphism,
intron 9/HinfI polymorphism and D19S207
polymorphism.
Allele frequencies of the five DNA poly-
morphisms studied are shown in Table 1.
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TABLE 1






Locus Enzyme Allele DM chrom. non-DM chrom. both chrom. non-DM chrom.
D19S63 PvuII 1 23 (1.00) 9 (0.39) 15 (0.35) 24 (0.36)
88chrom. 2 0 (0.00) 12 (0.52) 20 (0.47) 32 (0.49)
3 0 (0.00) 2 (0.008) 7 (0.16) 9 (0.13)
23 23 42 65
CKMM TaqI 1 0 (0.00) 4 (0.15) 8 (0.18) 12 (0.17)
98 chrom. NcoI 2 17 (0.63) 4 (0.15) 8 (0.18) 12 (0.17)
3 0 (0.00) 11 (0.40) 18 (0.41) 29 (0.40)
4 10 (0.37) 8 (0.30) 10 (0.22) 18 (0.25)
27 27 44 71
Alu 1 27 (1.00) 16 (0.59) 27 (0.61) 43 (0.60)
98 chrom. 2 0 (0.00) 11 (0.40) 17 (0.38) 28 (0.33)
27 27 44 71
Intron9 HinfI 1 0 (0.00) 15 (0.55) 20 (0.45) 35 (0.49)
98 chrom. 2 27 (1.00) 12 (0.44) 24 (0.54) 36 (0.50)
27 27 44 71
D19S207 1 0 (0.00) 0 (0.00) 9 (0.20) 9 (0.12)
98 chrom. 2 0 (0.00) 6 (0.22) 11 (0.25) 17 (0.23)
3 27 (1.00) 0 (0.00) 10 (0.22) 10 (0.14)
4 0 (0.00) 9 (0.33) 8 (0.18) 17 (0.23)
5 0 (0.00) 12 (0.44) 6 (0.13) 18 (0.25)
27 27 44 71
For Alu polymorphism, the allele 1
was shared by 100% of DM chromosomes
and 60% of non-DM chromosomes.
For intron 9/HinfI polymorphism the
allele 2 was shared by 100% of DM chro-
mosomes and 50% of non-DM chromo-
somes.
Likewise, all DM chromosomes shared
the allele 1 for D19S63 polymorphism,
whereas the same allele was shared by
36% of non-DM chromosomes.
For D19S207 polymorphism all DM
chromosomes shared the allele 3, the sa-
me allele was found in 14% of non-DM
chromosomes.
The analysis of CKMM polymorphism
revealed a genotype heterogeneity: the al-
lele 2 was found in 63% of DM chromo-
somes and the allele 4 in 37% of DM chro-
mosomes; in non-DM chromosomes the
allele 2 was found in 17%, and the allele 4
in 25%.
The polymorphisms at the five different
genetic markers were used to construct
compound haplotypes for DM and non-DM
chromosomes.
Only two haplotypes were present in
DM chromosomes: haplotype 1/2/1/2/3 (for
D19S63, CKMM, Alu, intron 9/HinfI and
D19S207 polymorphisms, respectively)
was found in 56% of DM chromosomes,
and haplotype 1/4/1/2/3 in 43% of DM
chromosomes.
Discussion
In this study the analysis of polymor-
phisms was performed to evaluate popu-
lation genetic characteristics of DM in
Croatian Istria. The haplotypes, linked to
DM phenotype defined by DM markers
with their polymorphisms, were estab-
lished. In this study of Istrian population
all DM patients shared the same allele
distribution for D19S63 polymorphism,
for Alu polymorphism, for intron 9/HinfI
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TABLE 2
FREQUENCIES OF HAPLOTYPES DEFINED BY MARKERS ON DM AND NON DM CHROMOSOMES
Alleles No of haplotypes





1 1 1 1 1 1 4
2 1 2 1 2 3 1 13
3 1 2 2 1 1 1
4 1 3 1 1 1 4
5 1 3 2 1 2 5
6 1 4 1 2 3 4 10
7 1 4 2 1 2 5
8 2 1 1 1 2 4
9 2 1 2 1 1 3
10 2 2 2 2 3 4
11 2 3 1 2 4 11
12 2 3 2 2 2 7
13 2 4 1 2 3 2
14 2 4 2 2 3 1
15 3 2 1 1 5 6
16 3 4 1 2 3 1
17 3 4 2 2 5 2
No of investigated subjects: 44 No of investigated chromosomes: 88
and for D19S207 polymorphism. For the
CKMM locus, two haplotypes segregating
with DM were found.
The determination of the molecular
basis of DM showed that the expansion of
an unstable CTG repeat sequence is re-
sponsible for most cases of DM5–11,25,26.
The finding of the same mutation in many
populations suggested a common ances-
try for the majority of cases4,5. Previously,
the linkage disequilibrium was detected
between polymorphic DNA markers with-
in the gene for apolipoprotein C2 (APOC2)
and the DM locus in isolated populations,
such as French-Canadian and Finnish23,24.
In 1991, Harley et al. reported the first
linkage disequilibrium between DM and
a tightly linked anonymous marker (D19-
S63) in a heterogeneous population4; a
similar result was later reported in the
Spanish and Japanese respective popu-
lation12,15. The gene for muscle type crea-
tine kinase (CKMM) and the DM locus
are closely linked29 but no linkage dis-
equilibrium was proved in the Spanish
and Finnish population12,13. Strikingly, in
all DM patients studied to date, the ex-
panded (CTG)n repeat is always asso- ci-
ated with the 1 kb insertion allele of a
two-allele Alu repeat insertion-deletion
polymorphism located in intron 8 of the
DM gene 5.3 kb upstream from the ex-
panded (CTG)n repeat5,10,14,15. Numerous
sequence polymorphisms due to a sin-
gle-base change have been identified in
the DM gene, recognized by altered re-
striction enzyme site. In intron 9 two al-
leles are detected by HinfI polymorphism,
the larger having the frequency 0.4719.
The analysis of the microsatellite GJ-
VSSM2 revealed linkage disequilibrium
between this extragenic marker and DM
mutation24.
All these findings prove a single an-
cestral mutation in DM, or a limited
number of mutations on the background
of a predisposing haplotype. The analysis
of markers closely linked to the DM mu-
tation locus revealed a consistent hap-
lotype on DM chromosomes30.
In the Croatian region Istria high DM
prevalence was reported. To check the
status of DM and non-DM chromosomes
in Istrian patients, we analyzed different
polymorphisms linked to the DM muta-
tion and compared the results with those
in some other populations (Table 3).
D19S63 is the first locus to reveal a
linkage disequilibrium with DM muta-
tion in a mixed population, and it does so
with the allele 3 in British, French-Cana-
dian, Finnish and Spanish respective po-
pulations4,12,13, whereas in the French14
and in our population with the allele 1.
This disequilibrium might be a good indi-
cation of the founder effect or it might be
the consequence of a short distance be-
tween the DM locus and the D19S63 mar-
ker on its proximal side.
Contrary to these findings in the Istri-
an population, 63% of DM chromosomes
at the CKMM locus carry the allele 2,
which is also present in 17% of unaffected
chromosomes; 37% of the DM chromo-
somes carry the allele 4, present in 25% of
non-DM chromosomes. These results make
the CKMM polymorphism a poor genetic
marker if applied on individual patient,
but it can be useful in constructing com-
pound haplotypes for population analy-
ses.
The complete allelic association was
found between the DM and intragenic
Alu insertion polymorphism in all inves-
tigated populations and in our study as
well. Our results are consistent with the
hypothesis that the CTG repeat expan-
sion occurred on one or a few ancestral
chromosomes carrying a large 1 kb inser-
tion allele.
For the intron 9/HinfI polymorphism
significant linkage disequilibrium was
detected between the DM mutation and
allele 2 in European, Canadian and South
African Caucasoid populations19,23,30,31.
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Our study confirmed a strong association
between the DM mutation and allele 2.
Canadian and South African Cauca-
soid populations were investigated using
a polymorphic microsatellite GJ-VSSM2
(D19S207). The analysis revealed a sig-
nificant allelic association between the
DM mutation and certain alleles. In South
African Caucasoid population the small-
est allele, allele 6 was found in 91% of
DM chromosomes31. In Canadians the al-
lele 5, was found on 88% of DM chro-
mosomes24. We have found a strong asso-
ciation between the DM mutation and
allele 3, revealed as Istrian particularity.
In conclusion, the analysis of the po-
lymorphisms was performed with the aim
of determining the characteristics of the
DM mutation in Croatian Istria and to
determine the ancestry of the DM muta-
tion in Istrian population32. However for
linkage disequilibrium calculations the
number of investigated chromosomes was
insufficient.
All living Istrian patients identified as
DM were included in the study. After ex-
tensive genealogical reconstruction we
could assign them to 9 different families.
Two haplotypes segregating with DM were
found in 9 Istrian DM families, differing
in the result for CKMM polymorphism.
As reported in other populations (Table
3), our results show a strong association
between the DM locus and D19S63, Alu,
intron 9/HinfI and D19S207 markers, su-
ggesting a common origin of the mutation
in the Istrian population.
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TABLE 3
DM AND NON DM CHROMOSOME ALLELE FREQUENCIES IN DIFFERENT POPULATIONS







DM nDM DM nDM DM nDM DM nDM DM nDM DM nDM
D19S63 1 1.00 0.36 0.45 0.59 0.45 0.62 0.25 0.55 0.32 0.57 0.07 0.56
2 0.00 0.49 0.18 0.28 0.06 0.19 0.00 0.16 0.10 0.27 0.00 0.26
3 0.00 0.13 0.37 0.13 0.48 0.19 0.75 0.28 0.59 0.16 0.93 0.18
CKMM 1 0.00 0.17 0.00 0.00
2 0.63 0.17 0.25 0.25
3 0.00 0.40 0.27 0.25
4 0.37 0.25 0.48 0.49
Alu 1 1.00 0.60 1.00 0.50 1.00 0.60
2 0.00 0.33 0.00 0.50 0.00 0.40
Intron
9(G/T)
1 0.00 0.49 0.00 0.49
2 1.00 0.50 1.00 0.51




5 0.00 0.25 0.88 0.06
6 0.00 0.91 0.12
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ZNA^AJKE MIOTONI^NE DISTROFIJE U ISTRI: MOLEKULARNO
GENETI^KI PRISTUP. DRUGI DIO: ANALIZA GENETI^KOG
POLIMORFIZMA
S A @ E T A K
Prevalencija miotoni~ne distrofije (DM) u hrvatskoj Istri je jedna od najvi{ih zabi-
lje`enih. Sa svrhom ustanovljenja populacijsko geneti~kih osobitosti DM lokusa u Istri,
analizirana su dva intragenska i tri ekstragenska polimorfna markera susjedna DM
lokusu. Southern blot tehnika kori{tena je pri analizi D19S63 lokusa, a PCR analiza
upotrebljena je za analizu CKMM, Alu polimorfizma, DMPK (G/T) intron 9/HinfI poli-
morfizma i za analizu D19S207 lokusa. Odre|eni su slo`eni haplotipovi koji segregi-
raju s DM. Potpuna udru`enost s DM ustanovljena je za D19S63, D19S207 lokus, te za
intron9/HinfI i Alu polimorfizam. Za lokus D19S63 svi DM kromosomi posjeduju alel 1,
za Alu polimorfizam svi DM kromosomi posjeduju alel 1, za D19S207 lokus svi DM
kromosomi posjeduju alel 3, za intron 9/HinfI polimorfizam svi DM kromosomi imaju
alel 2. Analiza CKMM polimorfizma pokazala je genetsku heterogeni~nost: u DM kro-
mosoma na|en je alel 2 ili alel 4.
Analiza haplotipa u populaciji hrvatske Istre potvrdila je podatke o neravnote`i po-
vezanosti Alu, intron9/HinfI, D19S63 i D19S207 polimorfnih markera s DM, kao i u
studijama do sada istra`ivanih populacija. Rezultati na{e studije analize haplotipa su-
geriraju zajedni~ko porijeklo DM mutacije u istarskoj populaciji.
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